ZYME
Zymeworks Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -15.4% ·
share flow -7.5% ·
net new positions -18.2%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 89 | -2 | 24.79M | $647.06M | +6 | −8 |
| Q1 2026 | 94 | +3 | 24.89M | $623.10M | +9 | −6 |
| Q4 2025 | 90 | -1 | 25.71M | $677.12M | — | −1 |
| Q3 2025 | 19 | +2 | 15.73M | $268.60M | +2 | −1 |
| Q2 2025 | 15 | +1 | 10.33M | $129.64M | +1 | — |
| Q1 2025 | 11 | 0 | 3.31M | $39.41M | +1 | −1 |
| Q4 2024 | 11 | -2 | 3.00M | $43.95M | — | −2 |
| Q3 2024 | 12 | +2 | 2.16M | $27.11M | +2 | — |
| Q2 2024 | 10 | — | 2.50M | $21.29M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 1.08M | — | $15.88M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 689.88K | -3.4% | $10.10M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 689.88K | -3.4% | $10.10M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Point72 Asset Management ✦ | 330.13K | +565.8% | $4.83M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 285.70K | +54.8% | $4.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 219.10K | -9.9% | $3.21M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 219.10K | -9.9% | $3.21M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Norges Bank ✦ (passive) | 201.70K | 0.0% | $2.95M | 0.0% | Held | 3 | SEC ↗ |
| 9 | Fisher Asset Management ✦ | 63.60K | 0.0% | $931,104 | 0.0% | Held | 3 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 58.36K | +180.5% | $854,361 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 58.36K | +180.5% | $854,361 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 26.07K | +4.9% | $381,724 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 26.07K | +4.9% | $381,724 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 26.07K | +4.9% | $381,724 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 26.07K | +4.9% | $381,724 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 21.58K | +17.6% | $316,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 20.84K | -4.3% | $305,098 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Arrowstreet Capital | $5.12M | was 0.0% |
| Marshall Wace | $2.63M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 209 holders, 70.12M shares, $1.75B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.